“Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma ”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026014, Jan. 2026, doi: 10.4084/MJHID.2026.014.